Pitavastatin-loaded procyanidins self-assembled nanoparticles alleviate advanced atherosclerosis via modulating

Yizhou Wu1, Hongyan Zhou2, Hao Liu3

  • 1College of Biology, Hunan University, Changsha 410082, China.

PubMed

Insights

This study developed hyaluronic acid-modified procyanidin nanoparticles loaded with pitavastatin (HA@PC@Pita NPs) to treat advanced atherosclerosis by restoring macrophage efferocytosis and enhancing cholesterol efflux.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Nanomedicine

Background:

  • Advanced atherosclerosis, a leading cause of death, involves apoptotic cell accumulation in necrotic cores.
  • Defective efferocytosis and cholesterol efflux in macrophages drive necrotic core formation in atherosclerosis.

Purpose of the Study:

  • To develop self-assembled procyanidin nanoparticles (PC NPs) loaded with pitavastatin (Pita) for treating advanced atherosclerosis.
  • To investigate the efficacy of hyaluronic acid-modified nanoparticles (HA@PC@Pita NPs) in restoring macrophage efferocytosis and cholesterol efflux.

Main Methods:

  • Constructed HA@PC@Pita NPs combining pitavastatin's efferocytosis restoration with procyanidins' cholesterol efflux enhancement.
  • Utilized in vitro assays to assess macrophage repolarization, ERK5/Mertk expression, and lipophagy.
  • Employed an ApoE-/- mice model to evaluate in vivo plaque stability and necrotic core clearance.

Main Results:

  • HA@PC@Pita NPs induced M1/M2 repolarization and upregulated ERK5/Mertk, restoring macrophage efferocytosis.
  • Nanoparticles significantly promoted cholesterol efflux via enhanced macrophage lipophagy.
  • In vivo studies demonstrated necrotic core clearance and improved plaque stability in a mouse model of advanced atherosclerosis.

Conclusions:

  • HA@PC@Pita NPs show potential for treating advanced atherosclerosis by addressing key pathological mechanisms.
  • The developed nanomedicine effectively restores macrophage function and enhances plaque stability.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
878
Inflammation01:38

Inflammation

Overview
55.3K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
696
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
106.0K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
92